NMAD NOMAD POWER SOLUTIONS, INC.
Pharmaceutical Preparations · Nasdaq · SEC CIK 1335105 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-474.2%
TTM EPS YoY-283.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-39.2%
ROA-31.9%
ROIC (approx.)-35.2%
Asset turnover—
Leverage & solvency
Liabilities / assets17.9%
Debt / equity0.00x
Current ratio0.78x
Interest coverage-191.93x
Cash quality & payout
Operating cash flow / net income0.46x
Accruals ratio-17.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q2*2026-06-30 | 2026Q1*2026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $472,000 | — | — | — | $652,000 | — | — | — |
| Cost of revenue | $470,000 | — | — | — | $539,000 | — | — | — |
| Gross profit | $2,000 | — | — | — | $113,000 | — | — | — |
| R&D expense | $473,000 | $62,250 | $333,376 | $52,118 | $31,000 | $60,648 | $91,457 | $34,830 |
| SG&A expense | $9.20M | $2.29M | $1.65M | $1.77M | $1.17M | $714,161 | $615,483 | $1.94M |
| Operating income | -$15.09M | -$2.35M | -$1.99M | -$1.82M | -$1.09M | -$774,809 | -$706,940 | -$613,497 |
| Interest expense | $103,000 | $851 | $3,096 | $3,756 | $352,000 | $1,810 | $3,135 | $4,432 |
| Net income | -$13.64M | -$2.19M | -$1.92M | -$2.61M | -$1.44M | -$775,673 | -$709,555 | -$617,694 |
| EPS (basic) | -0.74 | -0.16 | -0.18 | — | -1.30 | -0.29 | -0.29 | — |
| EPS (diluted) | -0.74 | -0.16 | -0.18 | — | -1.30 | -0.29 | -0.29 | — |
| Weighted avg. shares (diluted) | 18.43M | 13.48M | 10.89M | — | 1.11M | 2.72M | 2.47M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $5.65M | $12.67M | $3.25M | $156,000 | $2.89M | $887,212 | $1.38M | $1.04M |
| Receivables | $503,000 | — | — | $529,000 | — | — | — | — |
| Inventory | $6.43M | — | — | $6.67M | — | — | — | — |
| Current assets | $17.05M | $19.30M | $3.41M | $8.39M | $5.43M | $989,752 | — | $1.15M |
| PP&E, net | $455,000 | $6.61M | $6.61M | $474,000 | — | — | — | — |
| Goodwill | $94.34M | — | — | — | — | — | — | — |
| Intangibles | $171,000 | — | — | $147,000 | — | — | — | — |
| Total assets | $122.07M | $26.65M | $10.87M | $11.91M | $5.43M | $1.19M | $1.51M | $1.15M |
| Current liabilities | $21.82M | $1.50M | $1.22M | $18.05M | $521,422 | $537,122 | $355,098 | $318,284 |
| Short-term debt | $5.76M | — | — | $1.14M | — | — | — | — |
| Long-term debt | — | — | — | $5.47M | — | — | — | — |
| Total debt | — | — | — | $6.61M | — | — | — | — |
| Total liabilities | $21.91M | $1.66M | $1.69M | $23.66M | $14.37M | $8.84M | $355,098 | $318,284 |
| Shareholders' equity | $99.08M | $23.91M | $7.95M | -$11.75M | $4.91M | $651,456 | $1.16M | $827,219 |
| Net debt | — | — | — | $6.45M | — | — | — | — |
| Shares outstanding | 18.23M | 15.42M | 11.63M | 1.11M | 5.70M | 2.76M | 2.68M | 2.25M |
| Cash flow statement | ||||||||
| Operating cash flow | -$4.85M | -$1.61M | -$1.83M | -$1.09M | -$926,752 | -$487,485 | -$568,483 | -$598,675 |
| Investing cash flow | $19.15M | -$6.50M | -$24,859 | -$535,102 | — | — | — | — |
| Financing cash flow | -$16.37M | — | — | $3.84M | $5.56M | -$10,000 | $914,228 | — |
| Stock-based compensation | — | $622,614 | $82,176 | $243,974 | $776,611 | $240,499 | $99,738 | $77,977 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.